• Home
  • Getting Started
    • ChartMill OverviewGrowth TradersTechnical Swing Traders Long Term Investors
  • Tools
    • Stock ScreenerStock ChartsFull Screen Stock ChartsMarket MonitorSectorsEarningsAnalyzerInsider TradingUp- and Downgrades
  • Stock Market
    • Top Gainers and LosersNew 52 Week High and LowGap Up and Gap DownMost ActivePremarket MoversAfter-Hours MoversEarnings CalendarUSA Market OverviewCanada Market OverviewEurope Market Overview
  • Trading Ideas
  • News
  • Blog
  • Documentation
    • Documentation CenterVideosIndicatorsPropertiesScreener Market data
  • Popular Articles
    • Bull FlagsRelative StrengthPocket PivotsSupport and ResistanceRSI IndicatorMACD IndicatorPiotroski F-scoreSqueeze PlaysWeinsteinTechnical Breakout SetupsTrading TipsPremarket MoversGap Up StocksBest Dividend StocksBullish Engulfing PatternAscending Triangle PatternSwing TradingAll articles ...
  • Subscriptions
  • Swing Trading Course
  • Account
  • Disclaimer
AffiliatePrivacy
Logo image of IVA

INVENTIVA SA - ADR (IVA) Stock News

USA - NASDAQ:IVA - US46124U1079 - ADR

5.53 USD
+0.17 (+3.17%)
Last: 10/9/2025, 9:20:23 PM
5.05 USD
-0.48 (-8.68%)
After Hours: 10/9/2025, 9:20:23 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News

IVA Latest News, Press Relases and Analysis

All
Press Releases
17 hours ago - By: Benzinga - Mentions: HELE PLUG AZZ RACE ...
News Image

Helen of Troy, Ferrari, Apogee Therapeutics And Other Big Stocks Moving Lower In Thursday's Pre-Market Session

4 days ago - By: Benzinga - Mentions: IP IVR NAT MESO ...
News Image

Quantum Computing, Mesoblast And Other Big Stocks Moving Lower In Monday's Pre-Market Session

a month ago - By: Zacks Investment Research
News Image

How Much Upside is Left in Inventiva (IVA)? Wall Street Analysts Think 100.79%

a year ago - By: Yahoo Finance
News Image

Why Is Fatty-Liver Drug Developer Inventiva Stock Trading Higher On Monday?

2 years ago - By: The Motley Fool - Mentions: MDGL GALT GLMD VKTX ...
News Image

Madrigal Pharmaceuticals Wins Approval for the First Drug Targeting the Multibillion-Dollar NASH Market. Is the Stock a Screaming Buy?